Prof. Kunle Odunsi has been named the speaker for the University of Chicago’s Convocation ceremony on June 7.

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities ...

The University of Pennsylvania has taken a novel approach to ensure that women with suspicious adnexal lesions are referred ...

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...

In patients with a negative sentinel lymph node biopsy, omitting pelvic lymphadenectomy does not compromise disease-free ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...

Clinicians should adopt a risk-based, rather than biopsy-first, approach to encourage biopsy acceptance and improve early ...

Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for ...

with a 6-month PFS rate of 73.8% (95% CI 50.7-87.3), he said in a presentation at the Society of Gynecologic Oncology (SGO) annual meeting in Seattle. "Addition of metformin to letrozole and ...

today announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients with PROC in an oral presentation at the Society of Gynecologic Oncology (SGO ...